Updates

September 17, 2020September 17, 2020
Verona’s Ensifentrine Found to Ease Breathlessness, Improve Quality of Life

Nebulized ensifentrine (RPL554) — which works both to widen the airways and as an anti-inflammatory — showed a significant early effect on breathlessness in ... Read more
September 10, 2020September 10, 2020
SNG001 Can Safely Improve Lung Function in COPD Patients With Viral Infections, Interim Data Show

Synairgen‘s anti-viral therapy SNG001 has a good safety profile in people with chronic obstructive pulmonary disease (COPD), Phase 2 trial data show. The data ... Read more
September 8, 2020September 8, 2020
AstraZeneca’s New Data Shows Breztri Aerosphere Better for All Seasons

Breztri Aerosphere (budesonide/glycopyrronium/formoterol fumarate) outperformed Bevespi Aerosphere (glycopyrronium/formoterol fumarate) in reducing the rate of moderate or severe exacerbations in people with ... Read more
September 3, 2020September 3, 2020
Low-dose Morphine Improves Health in COPD Patients With Shortness of Breath, Phase 4 Trial Suggests

Regular, low-dose oral morphine led to significant health improvements in adults with advanced chronic obstructive pulmonary disease (COPD) who regularly experienced shortness of breath, ... Read more
September 1, 2020September 1, 2020
COPD Study: Fortified Whey Protein Beverage Increases Muscle Strength

Men with moderate-to-severe chronic obstructive pulmonary disease (COPD) who drank a beverage composed of whey protein fortified with magnesium and vitamin C had lower ... Read more

Subscribe to our mailing list

Get regular updates delivered to your email box.

Thanks! Please check your email for a confirmation email.

June 20, 2017June 20, 2017

Tilray Announces Support for Clinical Trial Evaluating Medical Cannabis Efficacy in COPD Patients

News

The effects of vaporized cannabis on symptoms associated with chronic obstructive pulmonary disease (COPD) are the target of a new clinical trial that stems from a partnership between medical cannabis products company Tilray and the Research Institute of the McGill University ... Read more

Updates

Verona’s Ensifentrine Found to Ease Breathlessness, Improve Quality of Life

SNG001 Can Safely Improve Lung Function in COPD Patients With Viral Infections, Interim Data Show

AstraZeneca’s New Data Shows Breztri Aerosphere Better for All Seasons

Low-dose Morphine Improves Health in COPD Patients With Shortness of Breath, Phase 4 Trial Suggests

COPD Study: Fortified Whey Protein Beverage Increases Muscle Strength

Blood Test for IL-32 May Diagnose COPD, Measure Severity, Study Says

New Potential Therapeutic Target – FFA4 Protein – Discovered for COPD

Phase 2 Trial Starts Testing Multiple Doses of Ensifentrine in Inhaler Formulation

University Given $3.9M to Advance Potential COPD Therapy to Clinical Testing

PR1P Peptide Reduces Lung Cell Death, Tissue Damage in Emphysema, Preclinical Study Shows

Healthy Diet Significantly Lowers COPD Risk, Review Study Finds

Subscribe to our mailing list

Free Online ‘Bootcamp’ Aims to Help Those With Lingering COVID-19 Effects

FDA Approves Breztri Aerosphere as COPD Maintenance Treatment

COPD Patients Using Metformin Should Be Aware of Added Risks, Study Shows

Younger Patients Feel Heavier Burden, Greater Impact of COPD, Global Survey Reveals

ProAir Digihaler for COPD and Asthma Now Available in US

COPD Seen as Potential Risk Factor for Lung and Other Cancers

Breztri Aerosphere Leads to Lower COPD Exacerbation Rate Compared With Dual Therapies, Trial Shows

Vitamin D Deficiency Linked to Lung Function Decline, Exacerbations, Study Finds

Pulmonary Rehabilitation Within 3 Months of Hospital Stay Improves Survival

Undersized Airways May Explain Why Some Nonsmokers Develop COPD

Lung Denervation System Named FDA Breakthrough Device

MUSC Resumes Clinical Trial Testing Targeted Lung Denervation

Lung Patients’ Improvement Amid UK Lockdown Spurs Call to Reduce Air Pollution

Stem Cell Therapy Benefits Patients with Severe Inflammation, Trial Data Show

COPD, Smoking Increase Death Risk in COVID-19 Patients, Study Says

Overweight COPD Patients at Greater Risk of Contracting COVID-19, Study Suggests

COPD Seen to Raise Risk of Lung Cancer in Non-smokers

Zephyr Valve Eases Breathlessness in Severe Emphysema, Trial Analysis Shows

Expansion of Unusual Stem Cell Subsets May Drive COPD Progression, Study Suggests

Triple Combo Therapy Reduces All-cause Mortality in COPD, Analysis Suggests

Industry leaders seek to advance innovative resources for rare and orphan disease communities amid COVID-19 outbreak

Surge in Telemedicine One ‘Good’ Outcome from COVID-19 Crisis, Doctors Say

American Thoracic Society Issues New Guidelines for COPD Treatments

MP1032 May Protect Lungs From Oxidative Stress, COPD Model Suggests

Lung Association Advises COPD Patients to Keep with Treatments in Pandemic

Tilray Announces Support for Clinical Trial Evaluating Medical Cannabis Efficacy in COPD Patients

Pin It on Pinterest